Week11, 2021
- **Viruses, illness, and deaths:** Influenza activity remains unusually low, with only 0.1% of respiratory specimens testing positive for influenza in clinical laboratories. Influenza A accounted for 61.9%, while Influenza B was 38.1%. One pediatric death has been reported this season. 12.1% of deaths were attributed to pneumonia, influenza, or COVID-19 (PIC), predominantly due to COVID-19.

- **U.S. virologic surveillance:** Clinical lab specimens show Influenza A constituted 35.3% cumulatively, and Influenza B 64.7%. Public health labs reported Influenza A (H1N1)pdm09 and H3N2 with minimal activity. Cumulative data reveal Influenza A cases dominated at 60.5%, with 39.5% attributed to Influenza B.

- **Cumulative hospitalization rate:** The cumulative hospitalization rate is 0.7 per 100,000 population, five times lower than during the 2011-12 low-severity season.

- **Trends of deaths attributed to influenza:** Among PIC deaths, none were associated with influenza this week, highlighting the dominant impact of COVID-19.

- **Percentage of Influenza A and Influenza B:** Influenza A accounts for 61.9% of current clinical positives and 60.5% of public health lab positives. Influenza B makes up 38.1% and 39.5%, respectively.

- **Novel Influenza virus:** One human infection with a novel influenza A(H1N1)v virus was reported from North Carolina. The case was linked to swine exposure with no human-to-human transmission identified.

- **Vaccination trends:** CDC continues recommending annual flu vaccination to prevent potential influenza complications. Low flu activity suggests compliance may be impacted by pandemic factors.

- **Outpatient respiratory illness visits:** 0.9% of outpatient visits were for influenza-like illness (ILI), below the national baseline of 2.6%. All jurisdictions reported minimal ILI activity.

- **Expectation of flu activity from CDC:** Influenza activity remains low but may increase in the coming months.

- **Other key factors:** An increasing ILI trend was observed in children aged 0â€“4 years over the past 10 weeks, while other age groups showed stable or decreasing trends. ILI data may be impacted by COVID-19 and alternative healthcare access.